Ai Feedback
Exact(6)
This observation confirmed that the toxic effects of HS oligosaccharides on the brain of ageing mice were mostly independent of microglial cell priming through TLR4 and MyD88.
Interestingly activated CD69+ BAL lymphocytes from N SRS vaccinated mice were equally composed of CD8+ and CD4+ cells whereas CD69+ BAL lymphocytes from non vaccinated or LT R192G) immunized mice were mostly CD8+ (Fig. 6B).
For example, C57BL/6J mice were mostly affected at the point which correlates with the activity of TRAIL-expressing influenza-specific CD8 T cells infiltrating the infected lungs [42].
The infected mice were mostly adult males captured in the spring and fall.
Splenic B cells from new born mice were mostly B220+, CD38+; CD38 appears prior to surface IgM and IgD, and its expression increases during development, reaching adult levels at 4 week of age.
Despite combining loss of VEGF binding with reduced NRP1 expression, Nrp1 Y297A/Y297A homozygous mice were mostly viable at birth, without the severe and lethal cardiovascular phenotypes of full or endothelial-specific Nrp1-null mutants.
Similar(54)
As previously reported, Map3k1-deficient mice are mostly non-viable on this background [29].
The Aβ burden in the old Tg mice was mostly represented, throughout the brain parenchyma, by big and radiating plaques with a dense Aβ core which was not significantly reduced by lithium treatment, as indicated by the lack of treatment effect in the maximum Aβ plaque area.
The neointima from both control and E2-treated mice was mostly composed of SMA-positive cells.
Established techniques for induction of renal failure in mice are mostly dependent on surgical interventions.
Preclinical CRC therapy studies in mice are mostly performed using localised, ectopically implanted (subcutaneous) primary tumours.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com